AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
MRK vs REGN Fundamental Comparison
| Metric | MRK | REGN |
|---|---|---|
| Revenue | $65.0B | $14.3B |
| Net Income | $18.3B | $4.5B |
| Net Margin | 28.1% | 31.4% |
| ROE | 34.7% | 14.4% |
| ROA | 13.3% | 11.1% |
| Current Ratio | 1.54x | 4.13x |
| Debt/Equity | 0.89x | 0.06x |
| EPS | $7.28 | $41.48 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MRK vs REGN: Frequently Asked Questions
Is MRK or REGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. MRK is rated BUY (80% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.
How does MRK compare to REGN fundamentally?
Merck & Co., Inc. has ROE of 34.7% vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 28.1% vs 31.4% respectively.
Which stock pays higher dividends, MRK or REGN?
MRK has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MRK or REGN for long term?
For long-term investing, consider that MRK has BUY rating with 80% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MRK vs REGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MRK vs REGN, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.